How to Buy Teva Pharmaceutical Industries Stock
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries is a pharmaceutical company located in Israel, which is part of the Healthcare sector, and is traded under the ticker TEVA on the NYSE exchange.
Teva Pharmaceutical Industries stock last closed at $16.99, down 4.07% from the previous day, and has decreased 2.36% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.33 percentage points. Teva Pharmaceutical Industries stock is currently +36.3% from its 52-week low of $12.47, and -25.48% from its 52-week high of $22.80.
As of Jun 13, 2025, there are 1.15B shares of TEVA outstanding. The market cap of TEVA is $19.49B. In the past 24 hours, 13.36M TEVA shares were traded.
How to Buy Teva Pharmaceutical Industries Stock
Not sure how to invest in Teva Pharmaceutical Industries stock? Here's how.
- Decide where to buy Teva Pharmaceutical Industries stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Teva Pharmaceutical Industries stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Select your method of payment and add your information.
- Analyze Teva Pharmaceutical Industries stock: The Teva Pharmaceutical Industries ticker symbol is TEVA. Is Teva Pharmaceutical Industries stock a good investment? Should you buy shares of TEVA? How do TEVA's underlying business fundamentals look? Do top analysts think Teva Pharmaceutical Industries is a good buy? Why has TEVA's stock price moved recently? (Hint: Our stock research website can help you figure out if TEVA is a good stock to buy).
- Execute your TEVA buy order: Decide if you will purchase TEVA shares at the current market price or use a limit order to purchase TEVA stock at a specific price.
- Get notifications regarding your TEVA investment: Create a watchlist to get the latest news on your investment in Teva Pharmaceutical Industries shares.
Step 1: Decide where to buy Teva Pharmaceutical Industries stock
You need a brokerage account in order to access the NYSE market and buy TEVA shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal details so you are able to buy TEVA stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've opened your account on the best investment app, you need to deposit funds:
Watch the video below if you need help transferring money into your new brokerage account.
Step 4: Analyze Teva Pharmaceutical Industries stock
Once you have identified the best place to buy Teva Pharmaceutical Industries stock, it's very important to evaluate their stock before you buy, so you actually understand the risk and opportunity.
Teva Pharmaceutical Industries shares data
Teva Pharmaceutical Industries Overview
WallStreetZen was built to help average investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on TEVA's stock page.
Is TEVA stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge TEVA's fair value.
Using relative valuations metrics:
- TEVA could be overvalued based on its P/B ratio of 3.11x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.26x
You can access more valuation research on TEVA's stock here.
TEVA Financial Summary
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the TEVA balance sheet.
Failed Financial Due Diligence Checks:
- TEVA profit margin has gone down from -3% to -7.7% in the past year.
- TEVA earnings of $471.00M is not sufficient to cover its interest payments.
- TEVA has a relatively high debt to equity ratio of 5.13.
- There are more long-term liabilities than short-term assets on the TEVA balance sheet.
- TEVA's operating cash flow of $1.27B allows it to safely service it's debt of $16.94B.
- Total TEVA debt is higher than 5 years ago, relative to shareholder equity.
Is Teva Pharmaceutical Industries stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 sell side analysts who monitor TEVA, the consensus analyst rating on Teva Pharmaceutical Industries is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest TEVA Analyst Forecasts
Balaji Prasad, a bottom 8% analyst from Barclays maintains TEVA with a strong buy rating and lowers their TEVA price target from $28.00 to $26.00, on Jan 30, 2025.
David Amsellem, a top 11% analyst from Piper Sandler maintains TEVA with a strong buy rating and raises their TEVA price target from $23.00 to $30.00, on Jan 17, 2025.
Piper Sandler's David Amsellem raised their price target on Teva Pharmaceutical Industries (NYSE: TEVA) by 30.4% from $23 to $30 on 2025/01/17. The analyst maintained their Strong Buy rating on the stock.
Ansellem reported that a meeting with Teva Pharmaceutical Industries management catalyzed their price target hike.
The analyst detailed that the development of anti-TL1A antagonist duvakitug beyond just inflammatory bowel disease in the wake of its recent positive results in ulcerative colitis and Crohn's disease was discussed.
Ansellem argued that "further multiple expansion for the stock is justified because of the compan's growing branded neuropsychiatry sales footprint and advancing pipeline."
You can dive deeper into what analysts are saying on the Teva Pharmaceutical Industries stock forecast page.
TEVA Technical Indicators
TEVA Growth Metrics
Last year, TEVA revenue was $16.62B. Over the last five year, TEVA's revenue has increased by -0.57% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 9.6%.
Find out more about TEVA's earnings and revenue performance here.
Latest Insiders Trades at TEVA
In the last 12 months, executives and large shareholders at TEVA have sold more shares than they have bought.
Matthew Shields, EVP Global Operations of TEVA, was the latest TEVA insider to sell. They sold $105,626.12 worth of TEVA shares on Jun 3, 2025.
Learn more about who owns TEVA stock here.
Does TEVA provide a stable income stream?
No, Teva Pharmaceutical Industries doesn't provide an income stream by paying out dividends.
What do other traders have to say about TEVA?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your TEVA buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want more help buying stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your TEVA investment
Now that you own some TEVA shares, you'll want to keep up with your investment.
Add TEVA to a watchlist to track your TEVA stock.
TEVA Feed
How to Buy Stock in Teva Pharmaceutical Industries
To summarize, here are the 6 steps you need to take to buy Teva Pharmaceutical Industries stock right now:
- Decide where to buy Teva Pharmaceutical Industries stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Teva Pharmaceutical Industries stock
- Execute your TEVA buy order
- Get notifications regarding your TEVA investment
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Teva Pharmaceutical Industries, click below.
More Stock Buying Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.